U.S. Leisure Stock News

NasdaqCM:POET
NasdaqCM:POETSemiconductor

The Bull Case For POET Technologies (POET) Could Change Following Major Funding And First Big Production Order

POET Technologies reported in the past that it had shifted from development to execution by securing more than US$225,000,000 in financing in 2025, adding a further US$150,000,000 in January 2026, and landing a production order above US$5,000,000 for its POET Infinity optical engines. This combination of large-scale funding and an initial multi-million-dollar production order highlights how POET is positioning its optical engine platform for commercial-scale manufacturing and customer...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Rezolve AI (RZLV) Revenue Surge To US$40.5 Million Tests Bearish Loss Concerns

Rezolve AI (RZLV) has just put fresh FY 2025 numbers on the table, with second half revenue of about US$40.5 million and a basic EPS loss of US$0.14, backed by trailing twelve month revenue of roughly US$46.8 million and a basic EPS loss of US$0.38. The company has seen revenue move from just US$0.1 million in the second half of FY 2024 to US$6.3 million in the first half of FY 2025 and then to US$40.5 million in the latest half, while basic EPS losses shifted from US$0.98 to US$0.25 and then...
NYSE:BKE
NYSE:BKESpecialty Retail

Is Buckle (BKE) Offering Value After Its Multi Year Share Price Surge

If you are wondering whether Buckle at around US$50.36 offers solid value or is pricing in too much optimism, this breakdown will help you frame that question clearly. The stock has had a mixed short term patch, with a 0.6% return over the last week, a 6.0% decline over the past month, and a 6.5% decline year to date, as well as a 42.9% return over the last year and 84.3% and 112.4% returns over the past 3 and 5 years. Recent coverage has focused on Buckle in the context of broader retail...
NYSE:CAH
NYSE:CAHHealthcare

Is Cardinal Health (CAH) Still Attractive After Recent Pullback And Strong Multi Year Gains

Wondering if Cardinal Health at around US$211 a share still offers value, or if most of the opportunity is already reflected in the price. The stock has returned 2.0% over the last week, seen a 7.8% decline over the last 30 days, yet is up 2.7% year to date and 55.8% over the past year, with very large gains over 3 and 5 years. Recent headlines have focused on Cardinal Health's broader role as a major healthcare distributor and solutions provider, which keeps attention on how its scale and...
NYSE:JOBY
NYSE:JOBYAirlines

Joby Test Flight Links Certification Progress To Future Air Taxi Revenue Potential

Joby Aviation (NYSE:JOBY) completed a test flight with its first conforming aircraft. The flight is a key step ahead of the company’s upcoming FAA Type Inspection Authorization certification. This milestone marks progress toward regulatory approval for future commercial operations. Joby Aviation, listed on the NYSE under the ticker JOBY, focuses on electric vertical take off and landing aircraft intended for short haul passenger trips. The recent test flight with a conforming aircraft comes...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

The Bull Case For Baidu (BIDU) Could Change Following Its ERNIE-Led AI And Digital Human Pivot

Baidu recently highlighted its evolution from a traditional search provider into an AI-centered technology platform, anchored by its ERNIE foundation model and Baidu Cloud, which now support a broad suite of multimodal AI applications for Chinese enterprises. A particularly distinctive development is Baidu’s use of Digital Human technology to automate marketing, sales, and customer engagement, signaling a push toward AI-native business operations across its ecosystem. We’ll now examine how...
NYSE:CB
NYSE:CBInsurance

Does Safe Harbor’s Exclusive Marine Deal Deepen Chubb’s Niche Strategy Or Narrow Its Opportunities (CB)?

In March 2026, Safe Harbor Marinas announced an exclusive partnership naming Chubb as the preferred insurance provider for members across more than 150 marinas, giving them access to Chubb’s Masterpiece Select Recreational Marine Insurance with wide-ranging coverage features. This deal highlights how Chubb is using specialized products, such as high-end recreational marine policies, to deepen reach in niche insurance segments with targeted customer bases. We’ll now examine how this...
NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

Assessing Tower Semiconductor (NasdaqGS:TSEM) Valuation As GlobalFoundries Lawsuits Put Future Growth In Focus

GlobalFoundries has filed multiple U.S. lawsuits accusing Tower Semiconductor (TSEM) of infringing 11 patents related to high performance chip manufacturing processes, and is seeking to block the importation and sales of certain Tower products. See our latest analysis for Tower Semiconductor. The legal action has arrived after a strong run, with a 1 month share price return of 40.53% and a 1 year total shareholder return of more than 4x. However, the 7 day share price return of 2.95% suggests...
NYSE:MHO
NYSE:MHOConsumer Durables

A Look At M/I Homes (MHO) Valuation After Recent Share Price Volatility

M/I Homes (MHO) has been drawing attention after recent share price swings, with the stock up about 3.2% on the day but showing a 13.9% decline over the past month. See our latest analysis for M/I Homes. That 3.2% 1 day share price gain comes after a 13.9% 30 day share price decline and a mildly negative year to date share price return. However, the 3 year total shareholder return near 100% and 5 year total shareholder return near 96% highlight how longer term holders have still seen strong...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Is Early RAS(ON) Pancreatic Cancer Data Altering The Investment Case For Revolution Medicines (RVMD)?

Revolution Medicines recently reported early clinical data showing that its RAS-targeting candidates daraxonrasib and zoldonrasib exhibited activity in second-line metastatic pancreatic cancer, an area with few effective treatments. This progress in directly targeting RAS(ON) via a molecular glue mechanism highlights a differentiated scientific approach in a difficult-to-treat tumor type. Next, we will examine how this early pancreatic cancer data, particularly the molecular glue RAS(ON)...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

A Look At Lyft (LYFT) Valuation After Recent Choppy Share Price Performance

What recent performance says about Lyft (LYFT) Recent trading in Lyft (LYFT) has been choppy, with the share price up about 5.1% over the past day and 1.1% over the past week, but showing weaker returns over the past month and past 3 months. Over longer periods the picture is mixed, with a roughly 8.7% total return over the past year and a much stronger multiyear total return, while year to date performance and the past 5 years reflect sizeable drawdowns from earlier levels. See our latest...
NasdaqGM:KOD
NasdaqGM:KODBiotechs

A Look At Kodiak Sciences (KOD) Valuation After Zenkuda GLOW2 Phase 3 Success And BLA Plans

Kodiak Sciences (KOD) is back in focus after reporting that its GLOW2 Phase 3 study of Zenkuda in diabetic retinopathy met key efficacy and safety endpoints, supporting a multi-indication, BLA-ready profile. See our latest analysis for Kodiak Sciences. The Zenkuda update arrives alongside sharp recent moves in the stock, with a 74.46% 7 day share price return and a 42.24% 30 day share price return. The 1 year total shareholder return is very large, suggesting momentum has picked up sharply...
NYSE:STNG
NYSE:STNGOil and Gas

Scorpio Tankers (STNG) Valuation After Fleet Sales And Newbuilding Plans

Scorpio Tankers (STNG) has been actively reshaping its fleet by agreeing to sell multiple MR and LR2 product tankers, including two 2015 built scrubber fitted vessels, while also arranging newbuilding deliveries through 2029. See our latest analysis for Scorpio Tankers. The latest vessel sales and newbuilding commitments come as Scorpio Tankers’ share price sits at US$74.66, with a 90 day share price return of 46.88% and a 1 year total shareholder return of 102.23%. This points to strong...
NYSE:CF
NYSE:CFChemicals

Has CF Industries Holdings (CF) Run Too Far After Its 66.9% One Year Surge?

Wondering if CF Industries Holdings is still reasonably priced after its recent run, or if it is already baking in a lot of optimism? This article focuses squarely on what you are paying for each dollar of value. With the share price at US$129.84 and returns of 2.3% over 7 days, 30.4% over 30 days, 62.0% year to date and 66.9% over 1 year, the stock has moved enough that it is worth pausing to check what those numbers might imply about risk and reward. Recent coverage has highlighted CF...
NasdaqGS:TMUS
NasdaqGS:TMUSWireless Telecom

T-Mobile US (TMUS) Valuation Check As New Device Fees Stir Fresh Questions On Customer Churn

T-Mobile US (TMUS) is drawing fresh attention after raising device restocking fees and introducing a $35 Device Connection Charge for Apple purchases, just as it faces higher customer cancellations and tougher wireless competition. See our latest analysis for T-Mobile US. The recent fee changes come after a softer 1-month share price return of 3.25% and a 1-day pullback of 1.83%, although the 3-year total shareholder return of 49.30% and 5-year total shareholder return of 66.21% still reflect...
OTCPK:FKYS
OTCPK:FKYSBanks

First Keystone (OTCPK:FKYS) Quarterly Loss Challenges Bullish Narrative Around Stable Net Interest Margin

First Keystone (FKYS) just wrapped up FY 2025 with fourth quarter revenue of US$7.8 million and a basic EPS loss of US$0.10, while the trailing twelve months show total revenue of US$40.3 million and EPS of US$0.99. Over recent periods the company has seen quarterly revenue move from US$10.4 million in Q4 2024 to US$11.5 million in Q2 2025 before landing at US$7.8 million in Q4 2025, with basic EPS shifting from US$0.37 in Q4 2024 to US$0.47 in Q2 2025 before slipping into a small loss in the...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

How Investors May Respond To Harrow (HROW) Upsizing Its 2030 Unsecured Notes For Growth Flexibility

Harrow recently completed a private fixed‑income offering of US$50.0 million in 8.625% senior unsecured notes due September 15, 2030, issued at 100.25% of par and guaranteed by certain subsidiaries. The new notes, fungible with Harrow’s existing US$250.0 million 2030 notes and sold to qualified institutional buyers under Rule 144A and Regulation S, further reshape the company’s capital structure to support general corporate and growth initiatives. Now we’ll examine how this additional...
NYSE:CRH
NYSE:CRHBasic Materials

A Look At CRH (NYSE:CRH) Valuation After Recent Share Price Volatility

CRH (NYSE:CRH) has drawn investor attention after recent share price volatility, with the stock closing at US$105.12 and showing mixed returns across the past week, month, past 3 months, and year to date. See our latest analysis for CRH. The recent 1 day share price return of 3.15% comes after a weaker stretch, with 30 day and year to date share price returns of 12.39% and 16.86% declines. At the same time, 1 year, 3 year, and 5 year total shareholder returns of 19.58%, 122.30%, and 160.89%...
NYSE:RJF
NYSE:RJFCapital Markets

Is Raymond James (RJF) Management Turnover Quietly Reshaping Its Long‑Term Wealth Strategy?

Raymond James said that Independent Contractor Division director Kirk Bell has been appointed president of the division, effective April 1, 2026, joining both the firm’s Senior Leadership and Private Client Group Executive Leadership teams after prior president Shannon Reid’s resignation. This leadership change comes as the firm balances softer capital markets activity with growth in asset management and private client revenues ahead of its upcoming fiscal Q2 2026 earnings release. Next,...
NYSE:NKE
NYSE:NKELuxury

The Bull Case For Nike (NKE) Could Change Following Soft Q3 Earnings And China-Led Outlook Cut

Nike, Inc. has reported its fiscal third-quarter 2026 results, with revenue holding roughly flat at US$11.28 billion while net income fell to US$520 million and earnings per share dropped to US$0.35 from US$0.54 a year earlier. Management’s outlook pointed to a revenue slip next quarter, driven by a sharp sales decline in China and a longer-than-expected turnaround timeline, even as North America and select product initiatives showed areas of progress. With China weakness now explicitly...
NYSE:ALSN
NYSE:ALSNMachinery

Allison Transmission Buyout Of Dana Unit Reshapes Growth And Valuation Profile

Allison Transmission Holdings (NYSE:ALSN) is acquiring Dana’s Off-Highway business, expanding its reach beyond on-highway applications. The deal adds exposure to off-highway markets such as construction, agriculture and mining, widening Allison’s addressable customer base. Investors now have new information to assess Allison’s mix of end markets, revenue sources and integration priorities. Allison Transmission Holdings, trading at $117.06, has seen its share price rise 18.3% year to date...
NYSE:CMI
NYSE:CMIMachinery

Is It Too Late To Consider Cummins (CMI) After Strong Multi Year Share Price Gains

If you are wondering whether Cummins at around US$538 per share is still a sensible entry or hold, the key question is how that price compares with what the company might reasonably be worth. The stock has seen mixed recent returns, with a 3.0% decline over the last 7 days and a 7.9% decline over the last 30 days, while still sitting on gains of 3.1% year to date, 73.8% over 1 year, 148.4% over 3 years, and 133.0% over 5 years. Recent attention on Cummins has focused on its position in the...
NYSE:ANET
NYSE:ANETCommunications

Is Arista Networks (ANET) Becoming NVIDIA’s Go-To AI Network Spine or Just One Key Partner?

In late March 2026, Truist Securities initiated coverage on Arista Networks and NVIDIA expanded its NVLink Fusion ecosystem, highlighting Arista’s role in high-speed AI data center networking and its ESUN collaboration within NVIDIA’s open infrastructure framework. This combination of fresh analyst attention and deeper integration into NVIDIA’s AI networking ecosystem underscores how central Arista’s Ethernet-based platforms have become to next-generation AI infrastructure buildouts. Now...
NasdaqGM:OLLI
NasdaqGM:OLLIMultiline Retail

The Bull Case For Ollie's (OLLI) Could Change Following Scale-Driven Economics Highlighted In Q4 FY2025 Results

Ollie's Bargain Outlet Holdings recently reported a strong fourth-quarter fiscal 2025 performance, emphasizing that greater scale is now improving its underlying economics beyond simple growth. Management highlighted how retail consolidation is enhancing access to closeout merchandise, real estate locations, and supplier bargaining power, supporting plans for roughly 10% annual unit growth and low-single-digit comparable sales. Next, we'll examine how this emphasis on scale-driven...